Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs01299272
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
|---|---|---|---|---|---|
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
OX4 | 3-FLUORO-4-HYDROXYBENZALDEHYDE O- (CYCLOHEXYLCARBONYL)OXIME | A,B,C | 2OOW | 0.72 |  |
Y13 | (2E)-3-(3,4-DIHYDROXYPHENYL)-N- [2-(4-HYDROXYPHENYL)ETHYL]ACRYLAMIDE | A | 2EW6 | 0.72 | |
DAH | 3,4-DIHYDROXYPHENYLALANINE | A,B | 1RNR | 0.75 | |
| DAH | 3,4-DIHYDROXYPHENYLALANINE | A | 6PAH | 0.75 | |
| DAH | 3,4-DIHYDROXYPHENYLALANINE | A,B | 1IVV | 0.75 | |
DTY | D-TYROSINE | A | 1C4B | 0.71 | |
| DTY | D-TYROSINE | A,L | 1ZEA | 0.71 | |
| DTY | D-TYROSINE | A,B,C,D,E,F, G,H | 1OF6 | 0.71 | |
| DTY | D-TYROSINE | A,B | 1UNO | 0.71 | |
| DTY | D-TYROSINE | A | 2IGZ | 0.71 | |
| DTY | D-TYROSINE | A,B,C,H,K,L | 2R5D | 0.71 | |
| DTY | D-TYROSINE | A,B | 2Q33 | 0.71 | |
| DTY | D-TYROSINE | H,S | 2H9E | 0.71 | |
| DTY | D-TYROSINE | A,B,C,H,K,L | 2R5B | 0.71 | |
| DTY | D-TYROSINE | A | 2IH0 | 0.71 | |
| DTY | D-TYROSINE | A | 1D7T | 0.71 | |
| DTY | D-TYROSINE | A,B | 1XA0 | 0.71 | |
TYB | TYROSINAL | A,B | 1KDZ | 0.71 | |
| TYB | TYROSINAL | A | 1Q11 | 0.71 | |
| TYB | TYROSINAL | A,B | 2J5B | 0.71 | |
| TYB | TYROSINAL | A,I | 1GA4 | 0.71 | |
| TYB | TYROSINAL | A,B,C | 1NLU | 0.71 | |
| TYB | TYROSINAL | A,B | 1KE1 | 0.71 | |
| TYB | TYROSINAL | A,B | 1H3F | 0.71 | |
| TYB | TYROSINAL | A,B | 1H3E | 0.71 | |
MCT | 4-METHYLCATECHOL | A | 1L4G | 0.71 | |
| MCT | 4-METHYLCATECHOL | A | 2EHZ | 0.71 | |
| MCT | 4-METHYLCATECHOL | A,B | 1DMH | 0.71 | |
OX5 | 4-HYDROXYBENZALDEHYDE O-(3,3-DIMETHYLBUTANOYL)OXIME | A,B,C | 2OOZ | 0.75 | |
DB1 | 2,3-DIHYDROXYBENZAMIDE | A,B,C | 1X71 | 0.7 | |
AEF | 4-(2-aminoethyl)phenol | A | 3BRA | 0.71 | |
B3Y | (3S)-3-AMINO-4-(4-HYDROXYPHENYL)BUTANOIC ACID | A | 3HF0 | 0.72 | |
| B3Y | (3S)-3-AMINO-4-(4-HYDROXYPHENYL)BUTANOIC ACID | A | 2OXK | 0.72 | |
| B3Y | (3S)-3-AMINO-4-(4-HYDROXYPHENYL)BUTANOIC ACID | A,B,C | 2OXJ | 0.72 | |
142 | CARBIDOPA | A,B | 1JS3 | 0.77 | |
LDP | L-DOPAMINE | A,B | 2A3R | 0.76 | |
| LDP | L-DOPAMINE | A | 5PAH | 0.76 | |
| LDP | L-DOPAMINE | A,B | 2QMZ | 0.76 | |
| LDP | L-DOPAMINE | A,B | 2VQ5 | 0.76 | |
1BA | 4-HYDROXY-N'-(4-ISOPROPYLBENZYL)BENZOHYDRAZIDE | A | 2GPP | 0.71 | |
K05 | (E)-3,4-DIHYDROXY-N'-[(2-METHOXYNAPHTHALEN- 1-YL)METHYLENE]BENZOHYDRAZIDE | A,B | 2I5J | 0.72 | |
TYC | L-TYROSINAMIDE | A | 2BF9 | 0.75 | |
| TYC | L-TYROSINAMIDE | A | 2OCI | 0.75 | |
AEG | 4-[(2R)-2-aminopropyl]phenol | A | 3BUF | 0.7 | |
LNR | L-NOREPINEPHRINE | A,B | 2QEO | 0.72 | |
| LNR | L-NOREPINEPHRINE | A | 3DYE | 0.72 | |
| LNR | L-NOREPINEPHRINE | A | 4PAH | 0.72 | |
SGI | 3-(4-hydroxyphenyl)propanamide | A,B | 2R9K | 0.77 | |
MTY | META-TYROSINE | A | 2TOH | 0.71 | |
| MTY | META-TYROSINE | A,B | 1BIQ | 0.71 | |
| MTY | META-TYROSINE | A | 1Q7O | 0.71 | |
OX3 | 4-HYDROXYBENZALDEHYDE O-(CYCLOHEXYLCARBONYL)OXIME | A,B,C | 2OOH | 0.74 | |
TY3 | 3-HYDROXY-L-TYROSINE | A,B | 2VH3 | 0.75 | |
4HL | 4-(HYDRAZINOMETHYL)PHENOL | A,B | 2E2U | 0.71 | |
IM3 | (2E)-3-(3,4-DIHYDROXYPHENYL)-2- IMINOPROPANOIC ACID | A,B,C,D | 2E82 | 0.75 | |
3BE | 3-bromo-N'-[(1E)-(3,5-dibromo-2,4- dihydroxyphenyl)methylidene]benzohydrazide | A,B,C,D,E,F | 3DOZ | 0.7 | |